November 28, 2016

Amicus Therapeutics Announces U.S. Regulatory Pathway for Migalastat for Fabry Disease

November 11, 2016

Journal of Medical Genetics Publishes Pivotal Phase 3 ATTRACT Study of Migalastat for Patients with Fabry Disease

November 7, 2016

Amicus Therapeutics Announces Third Quarter 2016 Financial Results and Corporate Updates